Pembrolizumab-Induced Migrating Cortico-Subcortical Brain LesionsAnn Neurol 89:1255-1256, Lambert, N.,et al, 2021
Neuromuscular Adverse Events Associated with Anti-PD-1 Monoclonal AntibodiesNeurol 92:663-674, Johansen, A.,et al, 2019